Chemoimmunotherapy Linked to HNSCC Response - Top-Institutions - MDSpire

Chemoimmunotherapy Linked to HNSCC Response

Higher pathologic response rates with chemoimmunotherapy versus immunotherapy alone call for phase 3 trials, but survival implications remain unknown.

  • By

  • Andrea Surnit

  • June 5, 2026

  • 6 min

Share

Top Institutions in Otolaryngology

Brief introduction explaining scope and methodology.

  • #1

    University of Chicago Medicine
    University of Chicago Medicine

    Chicago, Illinois

    Key Differentiators

    • Oncology

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, Massachusetts

    Key Differentiators

    • Oncology

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

  • #4

    Fox Chase Cancer Center
    Fox Chase Cancer Center

    Philadelphia, Pennsylvania

    Key Differentiators

    • Oncology

  • #5

    Mayo Clinic Comprehensive Cancer Center
    Mayo Clinic Comprehensive Cancer Center

    Rochester, Minnesota

    Key Differentiators

    • Oncology

Original Source(s)

Chemoimmunotherapy Linked to HNSCC Response

  • by Andrea Surnit

  • June 5, 2026

Related Content

Multiple primary head and neck cancers: a scenario-based framework for diagnosis and modern multidisciplinary management

Platelet-Rich Plasma Reduces Pain After Tonsillectomy

Randomized trial shows reduced postoperative pain and faster mucosal healing without increased bleeding risk

Tinnitus Severity Linked to Depression, Anxiety

Higher tinnitus burden tied to moderate-to-severe mood symptoms in clinic cohort